Study of how tuberculosis develops over time
Part of Infections clinical trials.
This study follows people with suspected or confirmed tuberculosis (TB), whether they have inactive “latent” TB or active TB. It helps researchers better understand TB’s natural course and may improve future testing and care by allowing collection and storage of samples.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have or might have TB infection (latent or active).
- You must be age 2 or older.
- You have a doctor outside NIH to manage your TB care and medicines, if needed with directly observed therapy (DOT).
- You’re willing to consent to storing your lab samples for future research.
- You can give consent yourself, or a legally authorized representative can consent for you.
- You must not be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the body fights mycobacterial infections (a type of bacteria) and aims to find immune problems that make some people more prone to these infections. It may help us understand why some people get sick and could lead to better treatments.
This trial studies whether reminder-based “vDOT” and small economic incentives can help people complete treatment for latent (sleeping) tuberculosis. If you have latent TB and are starting a standard medicine plan, it may help you stay on track and finish safely.
This study looks at how the immune system reacts in people with tuberculosis (TB), their close contacts, people with other lung diseases, and healthy volunteers. It aims to find better ways to diagnose and manage TB.
This study looks at how the immune system and natural germs in the lungs work in people who have recently been in close contact with someone with active tuberculosis (TB). It aims to better understand how the body responds to TB exposure.
This study looks for TB bacteria in the blood of people with active tuberculosis and their close contacts at home. It aims to find better ways to detect TB early and prevent its spread.
This study looks at immune system blood tests in adults being treated for active tuberculosis and/or latent tuberculosis infection. The goal is to see if these “immune biomarkers” can help guide or improve tuberculosis management.
Hear when a new Mycobacterium Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.